Found 11 matching trials
Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL) PHASE1 The goal of this clinical research study is to find the highest tolerable d...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina PHASE2 REGENERATE-COBRA will examine whether autologous stem cell treatment can im...
Show More Location
St Bartholomew's Hospital
Learn More & Join Trial
Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS) PHASE2 Multiple sclerosis - MS - affects 1.3m people worldwide, costing the Europe...
Show More Location
Southmead Hospital
Learn More & Join Trial
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia PHASE3 Drugs used in chemotherapy use different ways to stop cancer cells from div...
Show More Location
Cancer and Leukemia Group B
Learn More & Join Trial
Safety of Autologous MSC Infusion to Treat Epilepsy PHASE1 • The goal of this study was to evaluate the safety and efficacy of autolog...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Feasibility of the Use of Natural Killer Cells in Patients With Chronic Myeloid Leukemia PHASE1 The purpose of this study is to evaluate safety, feasibility and maximum to...
Show More Location
Centro Terapia e Tecnologia Celular
Learn More & Join Trial
Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts NA The goal of this study is to evaluate autologous MSCs as an alternative for...
Show More Location
Stem cell therapy center,Fuzhou General Hospital
Learn More & Join Trial
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia PHASE1 This phase I trial tests the safety, side effects and best dose of FH-WT1-E...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) PHASE1 This is a multicenter, open-label, phase 1, single arm study intended to de...
Show More Location
Local Institution - 119
Learn More & Join Trial
Precursor B Cell Acute Lymphoblastic Leukemia (B-ALL) Treated With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 PHASE1 This study is an investigational approach that uses immune cells, called "T...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial